INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 213 filers reported holding INSMED INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $28,785,000 | +10.1% | 1,336,368 | +0.8% | 5.06% | -15.5% |
| Q2 2022 | $26,156,000 | -42.9% | 1,326,368 | -31.9% | 5.99% | -44.7% |
| Q1 2022 | $45,796,000 | +28.0% | 1,948,784 | +48.4% | 10.83% | -8.2% |
| Q4 2021 | $35,783,000 | -1.1% | 1,313,607 | 0.0% | 11.80% | -10.3% |
| Q3 2021 | $36,177,000 | -1.0% | 1,313,607 | +2.3% | 13.16% | -12.4% |
| Q2 2021 | $36,539,000 | +11.5% | 1,283,887 | +33.5% | 15.02% | +8.8% |
| Q1 2021 | $32,759,000 | +2.3% | 961,797 | 0.0% | 13.81% | +20.6% |
| Q4 2020 | $32,018,000 | -5.7% | 961,797 | -9.0% | 11.45% | -20.4% |
| Q3 2020 | $33,965,000 | +22.0% | 1,056,797 | +4.6% | 14.39% | +15.9% |
| Q2 2020 | $27,837,000 | +70.1% | 1,010,797 | -1.0% | 12.42% | +25.1% |
| Q1 2020 | $16,363,000 | -30.7% | 1,020,797 | +3.2% | 9.92% | -30.7% |
| Q4 2019 | $23,617,000 | – | 988,999 | – | 14.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $100,415,822 | 8.32% |
| Deep Track Capital, LP | 6,500,000 | $110,825,000 | 4.55% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,932,138 | $49,992,953 | 2.11% |
| Endurant Capital Management LP | 230,006 | $3,921,602 | 2.01% |
| Ikarian Capital, LLC | 485,000 | $8,269,250 | 1.88% |
| MPM BioImpact LLC | 399,192 | $6,806,224 | 1.77% |
| SECTORAL ASSET MANAGEMENT INC | 516,092 | $8,799,369 | 1.69% |
| Novo Holdings A/S | 1,339,304 | $22,835,133 | 1.51% |
| First Light Asset Management, LLC | 750,883 | $12,802,555 | 1.15% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 143,794 | $2,451,688 | 1.01% |